Protective effect of talipexole on MPTP-treated planarian, a unique parkinsonian worm model

Japanese Journal of Pharmacology

Volumn 78, Issue 1, 1998, Pages 23-29

  Kitamura, Yoshihisa ^a   Kakimura, Jun Ichi ^a   Taniguchi, Takashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

MPTP; Parkinsonian worm model; Planarian; Pramipexole; Talipexole

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; PRAMIPEXOLE; TALIPEXOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; MORTALITY; NERVE REGENERATION; NONHUMAN; PARKINSONISM; SURVIVAL; TURBELLARIA;

EID: 0031665702     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.78.23     Document Type: Article

References (47)

1. Mizuno Y, Ikebe S, Hattori N, Nakagawa-Hattori Y, Mochizuki H, Tanaka M and Ozawa T: Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochim Biophys Acta 1271, 265-274 (1995)
2. Masalha R, Herishanu Y, Alfahel-Kakunda A and Silverman WF: Selective dopamine neurotoxicity by an industrial chemical: an environmental cause of Parkinson's disease? Brain Res 774, 260-264 (1997)
3. Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM and Kopin IJ: Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1, 249-254 (1979)
4. Langston JW, Ballard P, Tetrud JW and Irwin I: Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980 (1983)
5. Langston JW and Irwin I: MPTP: current concepts and controversies. Clin Neuropharmacol 9, 485-507 (1986)
6. Kopin IJ and Markey SP: MPTP toxicity: Implications for research in Parkinson's disease. Annu Rev Neurosci 11, 81-96 (1988)
7. Martelly I and Franquinet R: Planarian regeneration as a model for cellular activation studies. Trends Biol Sci 9, 468-471 (1984)
8. Welsh JH and Williams LD: Monoamine-containing neurons in planaria. J Comp Neurol 138, 103-116 (1970)
9. Algeri S, Carolei A, Ferretti P, Gallone C, Palladini G and Venturini G: Effects of dopaminergic agents on monoamine levels and motor behavior in planaria. Comp Biochem Physiol 74C, 27-29 (1983)
10. Venturini G, Stocchi F, Margotta V, Ruggieri S, Bravi, D, Bellantuono P and Palladini G: A pharmacological study of dopaminergic receptors in planaria. Neuropharmacology 28, 1377-1382 (1989)
11. Palladini G, Ruggeri S, Stocchi F, De Pandis MF, Venturini G and Margotta V: A pharmacological study of cocaine activity in planaria. Comp Biochem Physiol 115C, 41-45 (1996)
12. Sarnat HB and Netsky MG: The brain of planarian as the ancestor of the human brain. Can J Neurosci 12, 296-302 (1985)
13. Lange KW, Rausch W-D, Gsell W, Naumann M, Oestreicher E and Riederer P: Neuroprotection by dopamine agonists. J Neural Transm 43, Suppl 183-201 (1994)
14. Liu X-H, Kato H, Chen T, Kato K and Itoyama Y: Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil. J Neurol Sci 129, 9-14 (1995)
15. Iwasaki Y, Ikeda K, Shiojima T, Kobayashi T, Tagaya N and Kinoshita M: Deprenyl and pergolide rescue spinal motor neurons from axotomy-induced neuronal death in the neonatal rat. Neurol Sci 18, 168-170 (1996)
16. 2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Pharmacol Toxicol 62, 121-130 (1988)
17. Kohno Y, Kitamura Y, Nakazawa M and Nomura Y: The effects of talipexole on central monoamine receptors and metabolism in rats, with special reference to its effects on dopaminergic systems. Pharmacometrics 52, 233-241 (1996) (Abstr in English)
18. Kitamura Y, Kohno Y, Nakazawa M and Nomura Y: Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice. Jpn J Pharmacol 74, 51-57 (1997)
19. Eriksson KS and Panula P: Gamma-aminobutyric acid in the nervous system of a planarian. J Comp Neurol 345, 528-536 (1994)
20. Erzen I and Brzin M: Cholinergic mechanisms in Planaria torva. Comp Biochem Physiol 64C, 207-216 (1979)
21. Wikgren M, Reuter M, Gustafsson MKS and Lindroos P: Immunocytochemical localization of histamine in flatworms. Cell Tissue Res 260, 479-484 (1990)
22. Saitoh O, Oshima T, Agata K, Watanabe K and Nakata H: Molecular cloning of a novel ADP-ribosylation factor (ARF) expressed in planarians. Biochim Biophys Acta 1309, 205-210 (1996)
23. Saitoh O, Yuruzume E, Watanabe K and Nakata H: Molecular identification of a G protein-coupled receptor family which is expressed in planarians. Gene 195, 55-61 (1997)
24. Franquinet R, Le Moigne A and Hanoune J: The adenylate cyclase system of planaria Polycelis tenuis: Activation by serotonin and guanine nucleotides. Biochim Biophys Acta 539, 88-97 (1978)
25. 1A receptor positively coupled to planarian adenylate cyclase. Cell Biol Int Rep 16, 427-432 (1992)
26. Saitoh O, Yuruzume E and Nakata H: Identification of planarian serotonin receptor by ligand binding and PCR studies. Neuroreport 8, 173-178 (1996)
27. Pascolini R, Orlacchio A and Gargiulo AM: N-Acetyl-β-D-hexosaminidase activity levels and cytochemical localization in intact and regenerating planarian Dugesia lugubris. Comp Biochem Physiol 69B, 869-872 (1981)
28. Bowen ID, den Hollander JE and Lewis GHJ: Cell death and acid phosphatase activity in the regenerating planarian Polycelis tenuis Iijima. Differentiation 21, 160-167 (1982)
29. Javitch J, D'Amato RJ, Strittmatter SM and Snyder SH: Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of metabolite N-methyl-4-phenyl-pyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82, 2173-2177 (1985)
30. Shimada S, Kitayama S, Lin C-L, Patel A, Nanthakumar E, Gregor P, Kuhar M and Uhl G: Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-578 (1991)
31. Pacholczyk T, Blakely RD and Amara SG: Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350, 350-354 (1991)
32. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB and Marsden CD: Mitochondrial complex I deficiency in Parkinson's disease. Lancet I, 1269 (1989)
33. Castellani R, Smith MA, Richey PL and Perry G: Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 737, 195-200 (1996)
34. Mochizuki H, Goto K, Mori H and Mizuno Y: Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 137, 120-123 (1996)
35. Smith TS and Bennett JP Jr: Mitochondriak toxins in models of neurodegenerative diseases. I: in vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions. Brain Res 765, 183-188 (1997)
36. Sriram K, Pai KS, Boyd MR and Ravindranath V: Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice. Brain Res 749, 44-52 (1997)
37. Tatton NA and Kish SJ: In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77, 1037-1048 (1997)
38. Seaton TA, Cooper JM and Schapira AHV: Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res 777, 110-118 (1997)
39. Yoshikawa T, Minamiyama Y, Naito Y and Kondo M: Antioxidant properties of bromocriptine, a dopamine agonist. J Neurochem 62, 1034-1038 (1994)
40. Ogawa N, Tanaka K, Asanuma M, Kawai M, Masumizu T, Kohno M and Mori A: Bromocriptione protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro. Brain Res 657, 207-213 (1994)
41. Nishibayashi S, Asanuma M, Kohno M, Gómez-Vargas M and Ogawa N: Scavenging effects of dopamine agonists on nitric oxide radicals. J Neurochem 67, 2208-2211 (1996)
42. + and paraquat in Rana pipens. Life Sci 37, 1529-1538 (1985)
43. Schaeffer DJ: Planarians as a model system for in vivo tumorigenesis studies. Ecotoxicol Environ Safe 25, 1-18 (1993)
44. Saló E and Baguñà J: Regeneration and pattern formation in planarians: II. Local origin and role of cell movements in blastema formation. Development 107, 69-76 (1989)
45. Orii H, Agata K and Watanabe K: POU-domain genes in planarian Dugesia japonica: the structure and expression. Biochem Biophys Res Commun 192, 1395-1402 (1993)
46. Tarabykin VS, Lukyanov KA, Potapov VK and Lukyanov SA: Detection of planarian Antennapedia-like homeobox genes expressed during regeneration. Gene 158, 197-202 (1995)
47. Balavoine G and Telford MJ: Identification of planarian homeobox sequences indicates the antiquity of most Hox /homeotic gene subclasses. Proc Natl Acad Sci USA 92, 7227-7231 (1995)